nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—BCHE—diaphragm—ovarian cancer	0.0516	0.218	CbGeAlD
Ramipril—ACE—vein—ovarian cancer	0.0432	0.182	CbGeAlD
Ramipril—SLC15A1—epithelium—ovarian cancer	0.00931	0.0393	CbGeAlD
Ramipril—SLC15A1—endometrium—ovarian cancer	0.00834	0.0352	CbGeAlD
Ramipril—ACE—embryo—ovarian cancer	0.00818	0.0345	CbGeAlD
Ramipril—ACE—epithelium—ovarian cancer	0.00667	0.0282	CbGeAlD
Ramipril—ACE—decidua—ovarian cancer	0.0063	0.0266	CbGeAlD
Ramipril—BCHE—myometrium—ovarian cancer	0.00628	0.0265	CbGeAlD
Ramipril—SLC15A1—vagina—ovarian cancer	0.00625	0.0264	CbGeAlD
Ramipril—ACE—endometrium—ovarian cancer	0.00598	0.0253	CbGeAlD
Ramipril—SLC15A2—uterine cervix—ovarian cancer	0.00577	0.0244	CbGeAlD
Ramipril—ACE—gonad—ovarian cancer	0.00555	0.0234	CbGeAlD
Ramipril—SLC15A2—endometrium—ovarian cancer	0.00522	0.022	CbGeAlD
Ramipril—ACE—female reproductive system—ovarian cancer	0.00496	0.0209	CbGeAlD
Ramipril—BCHE—uterine cervix—ovarian cancer	0.00489	0.0206	CbGeAlD
Ramipril—ACE—bone marrow—ovarian cancer	0.00468	0.0198	CbGeAlD
Ramipril—ACE—female gonad—ovarian cancer	0.00451	0.019	CbGeAlD
Ramipril—BCHE—endometrium—ovarian cancer	0.00442	0.0187	CbGeAlD
Ramipril—SLC15A2—female reproductive system—ovarian cancer	0.00432	0.0182	CbGeAlD
Ramipril—BCHE—uterus—ovarian cancer	0.00407	0.0172	CbGeAlD
Ramipril—ACE—testis—ovarian cancer	0.004	0.0169	CbGeAlD
Ramipril—SLC15A2—female gonad—ovarian cancer	0.00393	0.0166	CbGeAlD
Ramipril—SLC15A2—vagina—ovarian cancer	0.00391	0.0165	CbGeAlD
Ramipril—BCHE—female reproductive system—ovarian cancer	0.00366	0.0155	CbGeAlD
Ramipril—SLC15A2—testis—ovarian cancer	0.00349	0.0147	CbGeAlD
Ramipril—BCHE—bone marrow—ovarian cancer	0.00346	0.0146	CbGeAlD
Ramipril—BCHE—vagina—ovarian cancer	0.00331	0.014	CbGeAlD
Ramipril—BCHE—testis—ovarian cancer	0.00295	0.0125	CbGeAlD
Ramipril—ACE—lymph node—ovarian cancer	0.0029	0.0122	CbGeAlD
Ramipril—SLC15A2—lymph node—ovarian cancer	0.00253	0.0107	CbGeAlD
Ramipril—BCHE—lymph node—ovarian cancer	0.00214	0.00904	CbGeAlD
Ramipril—Perindopril—ABCB1—ovarian cancer	0.00122	0.293	CrCbGaD
Ramipril—Cilazapril—ABCB1—ovarian cancer	0.00108	0.258	CrCbGaD
Ramipril—Lisinopril—ABCB1—ovarian cancer	0.00108	0.258	CrCbGaD
Ramipril—Enalapril—ABCB1—ovarian cancer	0.000792	0.19	CrCbGaD
Ramipril—Dysphagia—Doxorubicin—ovarian cancer	0.000573	0.000755	CcSEcCtD
Ramipril—Influenza—Doxorubicin—ovarian cancer	0.000573	0.000755	CcSEcCtD
Ramipril—Asthma—Doxorubicin—ovarian cancer	0.000573	0.000755	CcSEcCtD
Ramipril—Leukopenia—Docetaxel—ovarian cancer	0.000573	0.000755	CcSEcCtD
Ramipril—Eosinophilia—Doxorubicin—ovarian cancer	0.000568	0.000748	CcSEcCtD
Ramipril—Palpitations—Docetaxel—ovarian cancer	0.000566	0.000745	CcSEcCtD
Ramipril—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000566	0.000745	CcSEcCtD
Ramipril—Weight increased—Epirubicin—ovarian cancer	0.000564	0.000743	CcSEcCtD
Ramipril—Loss of consciousness—Docetaxel—ovarian cancer	0.000563	0.000741	CcSEcCtD
Ramipril—Pancreatitis—Doxorubicin—ovarian cancer	0.000562	0.000741	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000561	0.00074	CcSEcCtD
Ramipril—Cough—Docetaxel—ovarian cancer	0.000559	0.000736	CcSEcCtD
Ramipril—Angina pectoris—Doxorubicin—ovarian cancer	0.000558	0.000736	CcSEcCtD
Ramipril—Insomnia—Paclitaxel—ovarian cancer	0.000557	0.000734	CcSEcCtD
Ramipril—Convulsion—Docetaxel—ovarian cancer	0.000555	0.000731	CcSEcCtD
Ramipril—Paraesthesia—Paclitaxel—ovarian cancer	0.000553	0.000729	CcSEcCtD
Ramipril—Bronchitis—Doxorubicin—ovarian cancer	0.000551	0.000726	CcSEcCtD
Ramipril—Dyspnoea—Paclitaxel—ovarian cancer	0.000549	0.000724	CcSEcCtD
Ramipril—Somnolence—Paclitaxel—ovarian cancer	0.000548	0.000722	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000548	0.000722	CcSEcCtD
Ramipril—Chest pain—Docetaxel—ovarian cancer	0.000545	0.000718	CcSEcCtD
Ramipril—Myalgia—Docetaxel—ovarian cancer	0.000545	0.000718	CcSEcCtD
Ramipril—Arthralgia—Docetaxel—ovarian cancer	0.000545	0.000718	CcSEcCtD
Ramipril—Pancytopenia—Doxorubicin—ovarian cancer	0.000544	0.000717	CcSEcCtD
Ramipril—Nausea—Vinorelbine—ovarian cancer	0.000544	0.000717	CcSEcCtD
Ramipril—Renal failure—Epirubicin—ovarian cancer	0.000543	0.000715	CcSEcCtD
Ramipril—Dyspepsia—Paclitaxel—ovarian cancer	0.000542	0.000715	CcSEcCtD
Ramipril—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000542	0.000713	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000541	0.000713	CcSEcCtD
Ramipril—Stomatitis—Epirubicin—ovarian cancer	0.000538	0.000709	CcSEcCtD
Ramipril—Jaundice—Epirubicin—ovarian cancer	0.000538	0.000709	CcSEcCtD
Ramipril—Urinary tract infection—Epirubicin—ovarian cancer	0.000537	0.000708	CcSEcCtD
Ramipril—Conjunctivitis—Epirubicin—ovarian cancer	0.000537	0.000708	CcSEcCtD
Ramipril—Neutropenia—Doxorubicin—ovarian cancer	0.000536	0.000706	CcSEcCtD
Ramipril—Decreased appetite—Paclitaxel—ovarian cancer	0.000536	0.000706	CcSEcCtD
Ramipril—Dry mouth—Docetaxel—ovarian cancer	0.000533	0.000702	CcSEcCtD
Ramipril—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000533	0.000702	CcSEcCtD
Ramipril—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000532	0.000701	CcSEcCtD
Ramipril—Fatigue—Paclitaxel—ovarian cancer	0.000531	0.0007	CcSEcCtD
Ramipril—Sweating—Epirubicin—ovarian cancer	0.00053	0.000698	CcSEcCtD
Ramipril—Constipation—Paclitaxel—ovarian cancer	0.000527	0.000694	CcSEcCtD
Ramipril—Confusional state—Docetaxel—ovarian cancer	0.000527	0.000694	CcSEcCtD
Ramipril—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000523	0.000689	CcSEcCtD
Ramipril—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000522	0.000688	CcSEcCtD
Ramipril—Oedema—Docetaxel—ovarian cancer	0.000522	0.000688	CcSEcCtD
Ramipril—Anaphylactic shock—Docetaxel—ovarian cancer	0.000522	0.000688	CcSEcCtD
Ramipril—Weight increased—Doxorubicin—ovarian cancer	0.000522	0.000687	CcSEcCtD
Ramipril—Epistaxis—Epirubicin—ovarian cancer	0.000521	0.000687	CcSEcCtD
Ramipril—Sinusitis—Epirubicin—ovarian cancer	0.000518	0.000683	CcSEcCtD
Ramipril—Agranulocytosis—Epirubicin—ovarian cancer	0.000516	0.000679	CcSEcCtD
Ramipril—Shock—Docetaxel—ovarian cancer	0.000514	0.000677	CcSEcCtD
Ramipril—Nervous system disorder—Docetaxel—ovarian cancer	0.000512	0.000675	CcSEcCtD
Ramipril—Thrombocytopenia—Docetaxel—ovarian cancer	0.000511	0.000674	CcSEcCtD
Ramipril—Tachycardia—Docetaxel—ovarian cancer	0.00051	0.000672	CcSEcCtD
Ramipril—Feeling abnormal—Paclitaxel—ovarian cancer	0.000508	0.000669	CcSEcCtD
Ramipril—Skin disorder—Docetaxel—ovarian cancer	0.000507	0.000669	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000507	0.000668	CcSEcCtD
Ramipril—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000504	0.000664	CcSEcCtD
Ramipril—Renal failure—Doxorubicin—ovarian cancer	0.000502	0.000662	CcSEcCtD
Ramipril—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000501	0.00066	CcSEcCtD
Ramipril—Stomatitis—Doxorubicin—ovarian cancer	0.000498	0.000656	CcSEcCtD
Ramipril—Jaundice—Doxorubicin—ovarian cancer	0.000498	0.000656	CcSEcCtD
Ramipril—Anorexia—Docetaxel—ovarian cancer	0.000498	0.000656	CcSEcCtD
Ramipril—Conjunctivitis—Doxorubicin—ovarian cancer	0.000497	0.000655	CcSEcCtD
Ramipril—Urinary tract infection—Doxorubicin—ovarian cancer	0.000497	0.000655	CcSEcCtD
Ramipril—Hepatitis—Epirubicin—ovarian cancer	0.000496	0.000653	CcSEcCtD
Ramipril—Sweating—Doxorubicin—ovarian cancer	0.00049	0.000646	CcSEcCtD
Ramipril—Urticaria—Paclitaxel—ovarian cancer	0.00049	0.000645	CcSEcCtD
Ramipril—Oedema peripheral—Epirubicin—ovarian cancer	0.000489	0.000644	CcSEcCtD
Ramipril—Hypotension—Docetaxel—ovarian cancer	0.000488	0.000643	CcSEcCtD
Ramipril—Connective tissue disorder—Epirubicin—ovarian cancer	0.000487	0.000642	CcSEcCtD
Ramipril—Abdominal pain—Paclitaxel—ovarian cancer	0.000487	0.000642	CcSEcCtD
Ramipril—Body temperature increased—Paclitaxel—ovarian cancer	0.000487	0.000642	CcSEcCtD
Ramipril—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000483	0.000637	CcSEcCtD
Ramipril—Epistaxis—Doxorubicin—ovarian cancer	0.000482	0.000635	CcSEcCtD
Ramipril—Sinusitis—Doxorubicin—ovarian cancer	0.00048	0.000632	CcSEcCtD
Ramipril—Visual impairment—Epirubicin—ovarian cancer	0.000478	0.00063	CcSEcCtD
Ramipril—Agranulocytosis—Doxorubicin—ovarian cancer	0.000477	0.000628	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000476	0.000627	CcSEcCtD
Ramipril—Insomnia—Docetaxel—ovarian cancer	0.000472	0.000622	CcSEcCtD
Ramipril—Paraesthesia—Docetaxel—ovarian cancer	0.000469	0.000618	CcSEcCtD
Ramipril—Erythema multiforme—Epirubicin—ovarian cancer	0.000469	0.000618	CcSEcCtD
Ramipril—Dyspnoea—Docetaxel—ovarian cancer	0.000466	0.000614	CcSEcCtD
Ramipril—Somnolence—Docetaxel—ovarian cancer	0.000464	0.000612	CcSEcCtD
Ramipril—Tinnitus—Epirubicin—ovarian cancer	0.000462	0.000609	CcSEcCtD
Ramipril—Flushing—Epirubicin—ovarian cancer	0.00046	0.000606	CcSEcCtD
Ramipril—Dyspepsia—Docetaxel—ovarian cancer	0.00046	0.000606	CcSEcCtD
Ramipril—Hepatitis—Doxorubicin—ovarian cancer	0.000459	0.000605	CcSEcCtD
Ramipril—Decreased appetite—Docetaxel—ovarian cancer	0.000454	0.000598	CcSEcCtD
Ramipril—Hypersensitivity—Paclitaxel—ovarian cancer	0.000454	0.000598	CcSEcCtD
Ramipril—Oedema peripheral—Doxorubicin—ovarian cancer	0.000452	0.000596	CcSEcCtD
Ramipril—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000451	0.000594	CcSEcCtD
Ramipril—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000451	0.000594	CcSEcCtD
Ramipril—Fatigue—Docetaxel—ovarian cancer	0.00045	0.000593	CcSEcCtD
Ramipril—Immune system disorder—Epirubicin—ovarian cancer	0.000448	0.00059	CcSEcCtD
Ramipril—Mediastinal disorder—Epirubicin—ovarian cancer	0.000447	0.000589	CcSEcCtD
Ramipril—Constipation—Docetaxel—ovarian cancer	0.000447	0.000589	CcSEcCtD
Ramipril—Arrhythmia—Epirubicin—ovarian cancer	0.000443	0.000584	CcSEcCtD
Ramipril—Visual impairment—Doxorubicin—ovarian cancer	0.000442	0.000583	CcSEcCtD
Ramipril—Asthenia—Paclitaxel—ovarian cancer	0.000442	0.000583	CcSEcCtD
Ramipril—Alopecia—Epirubicin—ovarian cancer	0.000438	0.000577	CcSEcCtD
Ramipril—Pruritus—Paclitaxel—ovarian cancer	0.000436	0.000574	CcSEcCtD
Ramipril—Mental disorder—Epirubicin—ovarian cancer	0.000434	0.000572	CcSEcCtD
Ramipril—Erythema multiforme—Doxorubicin—ovarian cancer	0.000434	0.000572	CcSEcCtD
Ramipril—Erythema—Epirubicin—ovarian cancer	0.000432	0.000569	CcSEcCtD
Ramipril—Malnutrition—Epirubicin—ovarian cancer	0.000432	0.000569	CcSEcCtD
Ramipril—Feeling abnormal—Docetaxel—ovarian cancer	0.00043	0.000567	CcSEcCtD
Ramipril—Tinnitus—Doxorubicin—ovarian cancer	0.000428	0.000564	CcSEcCtD
Ramipril—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000427	0.000563	CcSEcCtD
Ramipril—Flushing—Doxorubicin—ovarian cancer	0.000426	0.000561	CcSEcCtD
Ramipril—Tension—Epirubicin—ovarian cancer	0.000424	0.000558	CcSEcCtD
Ramipril—Dysgeusia—Epirubicin—ovarian cancer	0.000423	0.000557	CcSEcCtD
Ramipril—Diarrhoea—Paclitaxel—ovarian cancer	0.000422	0.000556	CcSEcCtD
Ramipril—Nervousness—Epirubicin—ovarian cancer	0.000419	0.000552	CcSEcCtD
Ramipril—Muscle spasms—Epirubicin—ovarian cancer	0.000415	0.000547	CcSEcCtD
Ramipril—Immune system disorder—Doxorubicin—ovarian cancer	0.000414	0.000546	CcSEcCtD
Ramipril—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000414	0.000545	CcSEcCtD
Ramipril—Abdominal pain—Docetaxel—ovarian cancer	0.000413	0.000544	CcSEcCtD
Ramipril—Body temperature increased—Docetaxel—ovarian cancer	0.000413	0.000544	CcSEcCtD
Ramipril—Arrhythmia—Doxorubicin—ovarian cancer	0.00041	0.00054	CcSEcCtD
Ramipril—Dizziness—Paclitaxel—ovarian cancer	0.000408	0.000537	CcSEcCtD
Ramipril—Alopecia—Doxorubicin—ovarian cancer	0.000405	0.000534	CcSEcCtD
Ramipril—Mental disorder—Doxorubicin—ovarian cancer	0.000402	0.00053	CcSEcCtD
Ramipril—Ill-defined disorder—Epirubicin—ovarian cancer	0.000401	0.000528	CcSEcCtD
Ramipril—Erythema—Doxorubicin—ovarian cancer	0.000399	0.000526	CcSEcCtD
Ramipril—Malnutrition—Doxorubicin—ovarian cancer	0.000399	0.000526	CcSEcCtD
Ramipril—Agitation—Epirubicin—ovarian cancer	0.000397	0.000523	CcSEcCtD
Ramipril—Tension—Doxorubicin—ovarian cancer	0.000392	0.000516	CcSEcCtD
Ramipril—Vomiting—Paclitaxel—ovarian cancer	0.000392	0.000516	CcSEcCtD
Ramipril—Dysgeusia—Doxorubicin—ovarian cancer	0.000391	0.000515	CcSEcCtD
Ramipril—Malaise—Epirubicin—ovarian cancer	0.000389	0.000513	CcSEcCtD
Ramipril—Rash—Paclitaxel—ovarian cancer	0.000389	0.000512	CcSEcCtD
Ramipril—Dermatitis—Paclitaxel—ovarian cancer	0.000388	0.000512	CcSEcCtD
Ramipril—Nervousness—Doxorubicin—ovarian cancer	0.000388	0.000511	CcSEcCtD
Ramipril—Vertigo—Epirubicin—ovarian cancer	0.000388	0.000511	CcSEcCtD
Ramipril—Syncope—Epirubicin—ovarian cancer	0.000387	0.00051	CcSEcCtD
Ramipril—Leukopenia—Epirubicin—ovarian cancer	0.000386	0.000509	CcSEcCtD
Ramipril—Headache—Paclitaxel—ovarian cancer	0.000386	0.000509	CcSEcCtD
Ramipril—Hypersensitivity—Docetaxel—ovarian cancer	0.000385	0.000507	CcSEcCtD
Ramipril—Muscle spasms—Doxorubicin—ovarian cancer	0.000384	0.000506	CcSEcCtD
Ramipril—Palpitations—Epirubicin—ovarian cancer	0.000382	0.000503	CcSEcCtD
Ramipril—Loss of consciousness—Epirubicin—ovarian cancer	0.000379	0.0005	CcSEcCtD
Ramipril—Cough—Epirubicin—ovarian cancer	0.000377	0.000496	CcSEcCtD
Ramipril—Asthenia—Docetaxel—ovarian cancer	0.000375	0.000494	CcSEcCtD
Ramipril—Convulsion—Epirubicin—ovarian cancer	0.000374	0.000493	CcSEcCtD
Ramipril—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000371	0.000488	CcSEcCtD
Ramipril—Pruritus—Docetaxel—ovarian cancer	0.00037	0.000487	CcSEcCtD
Ramipril—Chest pain—Epirubicin—ovarian cancer	0.000368	0.000484	CcSEcCtD
Ramipril—Myalgia—Epirubicin—ovarian cancer	0.000368	0.000484	CcSEcCtD
Ramipril—Arthralgia—Epirubicin—ovarian cancer	0.000368	0.000484	CcSEcCtD
Ramipril—Agitation—Doxorubicin—ovarian cancer	0.000367	0.000484	CcSEcCtD
Ramipril—Anxiety—Epirubicin—ovarian cancer	0.000366	0.000483	CcSEcCtD
Ramipril—Nausea—Paclitaxel—ovarian cancer	0.000366	0.000482	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000365	0.000481	CcSEcCtD
Ramipril—Discomfort—Epirubicin—ovarian cancer	0.000363	0.000478	CcSEcCtD
Ramipril—Malaise—Doxorubicin—ovarian cancer	0.00036	0.000475	CcSEcCtD
Ramipril—Dry mouth—Epirubicin—ovarian cancer	0.000359	0.000474	CcSEcCtD
Ramipril—Vertigo—Doxorubicin—ovarian cancer	0.000359	0.000473	CcSEcCtD
Ramipril—Syncope—Doxorubicin—ovarian cancer	0.000358	0.000472	CcSEcCtD
Ramipril—Leukopenia—Doxorubicin—ovarian cancer	0.000358	0.000471	CcSEcCtD
Ramipril—Diarrhoea—Docetaxel—ovarian cancer	0.000357	0.000471	CcSEcCtD
Ramipril—Confusional state—Epirubicin—ovarian cancer	0.000355	0.000468	CcSEcCtD
Ramipril—Palpitations—Doxorubicin—ovarian cancer	0.000353	0.000465	CcSEcCtD
Ramipril—Anaphylactic shock—Epirubicin—ovarian cancer	0.000352	0.000464	CcSEcCtD
Ramipril—Oedema—Epirubicin—ovarian cancer	0.000352	0.000464	CcSEcCtD
Ramipril—Loss of consciousness—Doxorubicin—ovarian cancer	0.000351	0.000463	CcSEcCtD
Ramipril—Cough—Doxorubicin—ovarian cancer	0.000349	0.000459	CcSEcCtD
Ramipril—Shock—Epirubicin—ovarian cancer	0.000347	0.000457	CcSEcCtD
Ramipril—Convulsion—Doxorubicin—ovarian cancer	0.000346	0.000456	CcSEcCtD
Ramipril—Nervous system disorder—Epirubicin—ovarian cancer	0.000346	0.000455	CcSEcCtD
Ramipril—Dizziness—Docetaxel—ovarian cancer	0.000345	0.000455	CcSEcCtD
Ramipril—Thrombocytopenia—Epirubicin—ovarian cancer	0.000345	0.000455	CcSEcCtD
Ramipril—Tachycardia—Epirubicin—ovarian cancer	0.000344	0.000453	CcSEcCtD
Ramipril—Skin disorder—Epirubicin—ovarian cancer	0.000342	0.000451	CcSEcCtD
Ramipril—Hyperhidrosis—Epirubicin—ovarian cancer	0.000341	0.000449	CcSEcCtD
Ramipril—Chest pain—Doxorubicin—ovarian cancer	0.00034	0.000448	CcSEcCtD
Ramipril—Arthralgia—Doxorubicin—ovarian cancer	0.00034	0.000448	CcSEcCtD
Ramipril—Myalgia—Doxorubicin—ovarian cancer	0.00034	0.000448	CcSEcCtD
Ramipril—Anxiety—Doxorubicin—ovarian cancer	0.000339	0.000447	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000338	0.000445	CcSEcCtD
Ramipril—Discomfort—Doxorubicin—ovarian cancer	0.000336	0.000443	CcSEcCtD
Ramipril—Anorexia—Epirubicin—ovarian cancer	0.000336	0.000443	CcSEcCtD
Ramipril—Dry mouth—Doxorubicin—ovarian cancer	0.000333	0.000438	CcSEcCtD
Ramipril—Vomiting—Docetaxel—ovarian cancer	0.000332	0.000438	CcSEcCtD
Ramipril—Rash—Docetaxel—ovarian cancer	0.000329	0.000434	CcSEcCtD
Ramipril—Hypotension—Epirubicin—ovarian cancer	0.000329	0.000434	CcSEcCtD
Ramipril—Dermatitis—Docetaxel—ovarian cancer	0.000329	0.000434	CcSEcCtD
Ramipril—Confusional state—Doxorubicin—ovarian cancer	0.000329	0.000433	CcSEcCtD
Ramipril—Headache—Docetaxel—ovarian cancer	0.000327	0.000431	CcSEcCtD
Ramipril—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000326	0.00043	CcSEcCtD
Ramipril—Oedema—Doxorubicin—ovarian cancer	0.000326	0.00043	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000321	0.000423	CcSEcCtD
Ramipril—Shock—Doxorubicin—ovarian cancer	0.000321	0.000423	CcSEcCtD
Ramipril—Nervous system disorder—Doxorubicin—ovarian cancer	0.00032	0.000421	CcSEcCtD
Ramipril—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000319	0.000421	CcSEcCtD
Ramipril—Insomnia—Epirubicin—ovarian cancer	0.000319	0.00042	CcSEcCtD
Ramipril—Tachycardia—Doxorubicin—ovarian cancer	0.000318	0.000419	CcSEcCtD
Ramipril—Skin disorder—Doxorubicin—ovarian cancer	0.000317	0.000417	CcSEcCtD
Ramipril—Paraesthesia—Epirubicin—ovarian cancer	0.000316	0.000417	CcSEcCtD
Ramipril—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000315	0.000415	CcSEcCtD
Ramipril—Dyspnoea—Epirubicin—ovarian cancer	0.000314	0.000414	CcSEcCtD
Ramipril—Somnolence—Epirubicin—ovarian cancer	0.000313	0.000413	CcSEcCtD
Ramipril—Anorexia—Doxorubicin—ovarian cancer	0.000311	0.000409	CcSEcCtD
Ramipril—Nausea—Docetaxel—ovarian cancer	0.00031	0.000409	CcSEcCtD
Ramipril—Dyspepsia—Epirubicin—ovarian cancer	0.00031	0.000409	CcSEcCtD
Ramipril—Decreased appetite—Epirubicin—ovarian cancer	0.000306	0.000404	CcSEcCtD
Ramipril—Hypotension—Doxorubicin—ovarian cancer	0.000305	0.000401	CcSEcCtD
Ramipril—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000304	0.000401	CcSEcCtD
Ramipril—Fatigue—Epirubicin—ovarian cancer	0.000304	0.0004	CcSEcCtD
Ramipril—Constipation—Epirubicin—ovarian cancer	0.000301	0.000397	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000297	0.000391	CcSEcCtD
Ramipril—Insomnia—Doxorubicin—ovarian cancer	0.000295	0.000388	CcSEcCtD
Ramipril—Paraesthesia—Doxorubicin—ovarian cancer	0.000293	0.000386	CcSEcCtD
Ramipril—Dyspnoea—Doxorubicin—ovarian cancer	0.000291	0.000383	CcSEcCtD
Ramipril—Feeling abnormal—Epirubicin—ovarian cancer	0.00029	0.000383	CcSEcCtD
Ramipril—Somnolence—Doxorubicin—ovarian cancer	0.00029	0.000382	CcSEcCtD
Ramipril—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000288	0.00038	CcSEcCtD
Ramipril—Dyspepsia—Doxorubicin—ovarian cancer	0.000287	0.000378	CcSEcCtD
Ramipril—Decreased appetite—Doxorubicin—ovarian cancer	0.000283	0.000373	CcSEcCtD
Ramipril—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000281	0.000371	CcSEcCtD
Ramipril—Fatigue—Doxorubicin—ovarian cancer	0.000281	0.00037	CcSEcCtD
Ramipril—Urticaria—Epirubicin—ovarian cancer	0.00028	0.000369	CcSEcCtD
Ramipril—Constipation—Doxorubicin—ovarian cancer	0.000279	0.000367	CcSEcCtD
Ramipril—Abdominal pain—Epirubicin—ovarian cancer	0.000279	0.000367	CcSEcCtD
Ramipril—Body temperature increased—Epirubicin—ovarian cancer	0.000279	0.000367	CcSEcCtD
Ramipril—Feeling abnormal—Doxorubicin—ovarian cancer	0.000269	0.000354	CcSEcCtD
Ramipril—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000267	0.000351	CcSEcCtD
Ramipril—Hypersensitivity—Epirubicin—ovarian cancer	0.00026	0.000342	CcSEcCtD
Ramipril—Urticaria—Doxorubicin—ovarian cancer	0.000259	0.000341	CcSEcCtD
Ramipril—Abdominal pain—Doxorubicin—ovarian cancer	0.000258	0.00034	CcSEcCtD
Ramipril—Body temperature increased—Doxorubicin—ovarian cancer	0.000258	0.00034	CcSEcCtD
Ramipril—Asthenia—Epirubicin—ovarian cancer	0.000253	0.000333	CcSEcCtD
Ramipril—Pruritus—Epirubicin—ovarian cancer	0.000249	0.000328	CcSEcCtD
Ramipril—Diarrhoea—Epirubicin—ovarian cancer	0.000241	0.000318	CcSEcCtD
Ramipril—Hypersensitivity—Doxorubicin—ovarian cancer	0.00024	0.000316	CcSEcCtD
Ramipril—Asthenia—Doxorubicin—ovarian cancer	0.000234	0.000308	CcSEcCtD
Ramipril—Dizziness—Epirubicin—ovarian cancer	0.000233	0.000307	CcSEcCtD
Ramipril—Pruritus—Doxorubicin—ovarian cancer	0.000231	0.000304	CcSEcCtD
Ramipril—Vomiting—Epirubicin—ovarian cancer	0.000224	0.000295	CcSEcCtD
Ramipril—Diarrhoea—Doxorubicin—ovarian cancer	0.000223	0.000294	CcSEcCtD
Ramipril—Rash—Epirubicin—ovarian cancer	0.000222	0.000293	CcSEcCtD
Ramipril—Dermatitis—Epirubicin—ovarian cancer	0.000222	0.000292	CcSEcCtD
Ramipril—Headache—Epirubicin—ovarian cancer	0.000221	0.000291	CcSEcCtD
Ramipril—Dizziness—Doxorubicin—ovarian cancer	0.000216	0.000284	CcSEcCtD
Ramipril—Nausea—Epirubicin—ovarian cancer	0.000209	0.000276	CcSEcCtD
Ramipril—Vomiting—Doxorubicin—ovarian cancer	0.000207	0.000273	CcSEcCtD
Ramipril—Rash—Doxorubicin—ovarian cancer	0.000206	0.000271	CcSEcCtD
Ramipril—Dermatitis—Doxorubicin—ovarian cancer	0.000205	0.000271	CcSEcCtD
Ramipril—Headache—Doxorubicin—ovarian cancer	0.000204	0.000269	CcSEcCtD
Ramipril—Nausea—Doxorubicin—ovarian cancer	0.000194	0.000255	CcSEcCtD
